Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_assertion description "[This implies that COX-2 expression in both cancer cells and stromal cells within the tumor microenvironment may play an important role in upregulating the expression of the angiogenic factor VEGF and tumor angiogenesis in NSCLC and explains, in part, the adverse prognostic effect of COX-2 overexpression in patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_assertion evidence source_evidence_literature NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_assertion SIO_000772 15704107 NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_assertion wasDerivedFrom befree-20140225 NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_assertion wasGeneratedBy ECO_0000203 NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP535863.RA1HgSSYbqmHxL-A4JiTUE6qCpxOoe_hVjTX07VMVtzUE130_provenance.